Complaint Alleges Ellume Failed To Pay Refunds After Class I Recall Of OTC COVID-19 Tests
Executive Summary
Complaint filed in Maryland federal court says Australian firm, which received more than $230 from US government to boost production of its OTC COVID-19 diagnostic tests available to US consumers, should’ve offered refunds to consumers who bought tests the company has recalled due to false positive tests.